Article
Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.
Transplantation proceedings - 1 Nov 2016
Sanchez Antolin G, Testillano M, Pascasio J M, Narvaez Rodriguez I, Prieto M, Otero A, Herrero J I, Londoño M, Fernandez Vazquez I, Castells L
Abstract excerpt
BACKGROUND: Patients with hepatitis C virus (HCV) genotype 4 infection are poorly represented in clinical trials of 2nd-generation direct-acting antivirals (DAAs), and more data are needed to help guide treatment decisions. We still have even fewer data concerning liver transplant patients. Simeprevir (SIM) and sofosbuvir (SOF) combination is useful to treat this genotype. The aim of this study was to know the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.